Paid Clinical Trials in Omaha, NE
As of July 2026, 583 paid clinical trials are recruiting in Omaha, Nebraska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Omaha offers studies at sites including University of Nebraska Medical Center for conditions such as Breast Cancer, Multiple Myeloma, Prostate Cancer, Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Omaha
Trials by drug in Omaha
Filter results
Newly added in Omaha
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
The Impact of Enhanced Music & Natural Visuals on Emotional Health
531 clinical trials
↓ Download CSVAn Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Top Research Study Locations in Omaha
Researchers run research studies in Omaha, NE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Nebraska Medical Center | Acute Myeloid Leukemia, Multiple Myeloma, Heart Failure | 212 |
| Nebraska Cancer Specialists | Breast Cancer, Colorectal Cancer, Prostate Cancer | 37 |
| Nebraska Medicine-Village Pointe | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 | 36 |
| Children's Hospital and Medical Center of Omaha | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 29 |
| Nebraska Methodist Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 27 |
| Alegent Health Bergan Mercy Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Malignant Solid Neoplasm | 26 |
| Alegent Health Immanuel Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Malignant Solid Neoplasm | 23 |
| Alegent Health Lakeside Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Malignant Solid Neoplasm | 23 |
| Creighton University Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Prostate Adenocarcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 16 |
| Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Ovarian Carcinoma, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 | 14 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Chronic Obstructive Pulmonary Disease, Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD) | 13 |
| University of Nebraska | Adenocarcinoma, Pancreatic Ductal, Adenovirus Infections, Brain Tumor | 11 |
| Creighton University | Age-associated Muscle Loss, Anxiety and Mood Disorders, Bilateral Vestibular Hypofunction | 8 |
| Boys Town National Research Hospital | Developmental Language Disorder, Autism, Autism Spectrum Disorder | 6 |
| Nebraska Medicine | Cachexia, Choline Deficiency, Engagement | 6 |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 6 |
| Children's Nebraska | Acute Kidney Injury, Bronchiolitis Acute, Chronic Kidney Disease(CKD) | 5 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, HIV Infections | 5 |
| Nebraska Medical Center | Atrial Fibrillation, Cardiac Arrest, Cardiopulmonary Arrest | 5 |
| Unversity of Nebraska Medical Center | Chronic Pancreatitis, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease | 4 |
| Velocity Clinical Research, Omaha | COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease, Cortisol Excess | 4 |
| XCancer | Prostate Cancer, B7H3, Castration Resistant Metastatic Prostate Cancer | 4 |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Follicular Lymphoma (FL), Metastatic Castration Resistant Prostate Cancer (mCRPC), Refractory Diffuse Large B-cell Lymphoma | 4 |
| Adult & Pediatric Urology | Benign Prostatic Hyperplasia (BPH), Localized Prostate Cancer, Overactive Bladder (OAB) | 3 |
| Children's Hospital & Medical Center | Acute Treatment of Migraine, Pediatric Migraine | 3 |
Active & Upcoming Studies in Omaha (2026)
Recruiting trials in Omaha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (257 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Cardiovascular (38 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids · Phase 1, Phase 2 · University of Nebraska
Diabetes & metabolic (18 active studies)
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (16 active studies)
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- Attention and Eye Movement in Parkinson's Disease · University of Nebraska
Vaccines (9 active studies)
- A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) · Phase 1, Phase 2 · AstraZeneca
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · ModernaTX, Inc.
Pediatric (9 active studies)
- Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy · University of Nebraska
- iAmHealthy Clinical Practice Guideline (CPG) · University of Kansas Medical Center
Eye & vision (6 active studies)
- A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK · Phase 4 · Vance Thompson Vision
- The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma · Vance Thompson Vision
Mental health & behavior (5 active studies)
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
HIV / STI (2 active studies)
Common conditions studied in Omaha
- Breast Cancer (15 active studies)
- Multiple Myeloma (14 active studies)
- Prostate Cancer (14 active studies)
- Non-Small Cell Lung Cancer (11 active studies)
- Heart Failure (10 active studies)
- Ovarian Cancer (10 active studies)
Leading research sponsors in Omaha
- University of Nebraska
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Omaha?
There are approximately 583 recruiting clinical trials in Omaha, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Omaha pay participants?
Most recruiting trials in Omaha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Omaha?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Omaha?
The most common conditions under active study in Omaha include Breast Cancer (15), Multiple Myeloma (14), Prostate Cancer (14), Non-Small Cell Lung Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Omaha?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Omaha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Omaha?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Omaha?
Recruiting research sites in Omaha include University of Nebraska Medical Center, Nebraska Cancer Specialists, Nebraska Medicine-Village Pointe, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Omaha right now?
The largest active categories in Omaha are Cancer & tumors (257), Cardiovascular (38), Diabetes & metabolic (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.